Question 1

How many shares of APRE does BNP PARIBAS FINANCIAL MARKETS own?

Accepted Answer

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS holds 45,211 shares of APRE (APREA THERAPEUTICS INC).

Question 2

What is BNP PARIBAS FINANCIAL MARKETS's APRE position worth?

Accepted Answer

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS's APRE position is worth $36,273.

Question 3

Is BNP PARIBAS FINANCIAL MARKETS buying or selling APRE?

Accepted Answer

In 2026-Q2, BNP PARIBAS FINANCIAL MARKETS increased their APRE position (+13.6% change in shares).

Question 4

When did BNP PARIBAS FINANCIAL MARKETS first buy APRE?

Accepted Answer

Based on available 13F filings, BNP PARIBAS FINANCIAL MARKETS first reported a position in APRE in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	45,211	+13.6%	$36,273	0.0%	$0.80	15
2026-Q1	Increased	39,817	+45.7%	$30,376	0.0%	$0.85	18
2025-Q4	Increased	27,332	+59.5%	$23,314	0.0%	$0.89	19
2025-Q3	Increased	17,132	+11.0%	$25,270	0.0%	$1.51	15
2025-Q2	Increased	15,432	+12.6%	$26,234	0.0%	$1.67	15
2025-Q1	Increased	13,711	+5.4%	$27,970	0.0%	$2.09	14
2024-Q4	New	13,011	-	$42,676	0.0%	$3.48	31

APRE7 quarters

APRE
7 quarters